The aim of this study is to evaluate the effects of hypercholesterolemia in thoracic aorta (TA), mesenteric artery (MA), renal artery (RA), and corpus cavernosum (CC) isolated from cholesterolfed rabbits. For determination of the maximum detrimental effect, vasorelaxation and vasoconstriction results of arteries and CC have been compared. Animals were fed with a diet that contained 2% w/w cholesterol and 2% w/w high cholesterol plus resveratrol (4 mg kg -1 per day) for 6-week duration. Total cholesterol levels in the plasma were measured. Vascular and endothelial functions in RA, TA, MA, and CC were assessed by isolated tissue bath with cumulative doses of acetylcholine and sodium nitroprusside. The statistical significance of differences of groups was analyzed by means of one-way ANOVA or Student's t-test. P-values o0.05 were considered significant. There have been no significant changes on plasma total cholesterol levels between cholesterol and cholesterol þ resveratrol-treated groups. Vasorelaxation responses to acetylcholine in resveratroltreated group showed significant changes when compared with hypercholesterolemic group. No statistically significant differences were seen between non-receptor-mediated vasorelaxation responses between the three groups. Resveratrol might be an effective treatment in the prevention of atherosclerotic changes in arteries and CC. The initial effects of hypercholesterolemia on erectile dysfunction and endothelial dysfunction may be precluded with resveratrol. This protective effect may also ensure the prevention of coronary arterial diseases and renovascular diseases in hypercholesterolemic patients.
Introduction
Atherosclerosis is one of the main causes of morbidity and mortality in cardiovascular disorders in the world. Several factors are associated with the onset and progression of atherosclerosis, that is disruption of the immune system, glycation end products, infectious agents, smoking, high blood pressure, endothelial dysfunction, diabetes, hypercholesterolemia, hyperhomocysteinemia, hypertriglyceridemia, and low HDL cholesterol. Atherosclerosis uniformly affects all major vascular beds. Nevertheless, simultaneously viewing the clinical manifestations of vascular diseases is rarely possible for patients. The reason for this could be attributed to the different sizes of arteries supplying various regions (that is penis, mesenteric artery (MA), aorta, brain). Clinically, it has been shown that erectile dysfunction (ED) is common in patients with subclinical or symptomatic coronary arterial disease, [1] [2] [3] [4] and conversely, recent studies suggest that ED may occur before either a chronic disease presentation or an acute coronary event. [5] [6] [7] Treatments that reduce endothelial damage will ensure protection throughout vasculature with potential benefits for preventing coronary arterial disease as well as treating ED connected with hypercholesterolemia. It has been pointed out that lipid-lowering therapies such as cholesterol absorption inhibitors, bile acid resins, nicotinic acid, fibrates, and 3-hydroxymethyl-3-methylglutaryl coenzyme A reductase inhibitors, which have been widely used to prevent atherosclerosis, 8 have shown beneficial effects on ED. Some of these drugs have been found to improve penile erection. Drugs that improve endothelial function in the cavernous arteries and the corpus cavernosum (CC) tissue hold great promise in treating or at least minimizing the vascular damage that contributes to ED. 9 Although these drugs are generally well tolerated, severe adverse effects can occur in a minority of patients. Besides, some groups of patients do not respond to the treatment with a reduction in coronary heart disease progression. 10 Beyond lowering cholesterol, pleiotropic effects of these drugs are also thought to have an important function in prevention of ED. The relationship between reducing cholesterol and ED development remains questionable. Therefore, new treatment strategies, which may be opted to prevent the development and progression of the disease, are still needed to reduce the burden of ED.
Resveratrol (trans-3,5,4 0 -trihydroxystilben) is a polyphenol (phytoalexin) naturally found mostly in red wine and different therapeutic plants. By in vitro experiments, it has been displayed that the cardiovascular protective effects of resveratrol might be through a variety of mechanisms: it inhibits the proliferation of smooth muscle cells, platelet aggregation, and the oxidation of LDL cholesterol; it also reduces the synthesis of lipids and eicosanoids, which promote inflammation and atherosclerosis. To our knowledge, there has been no study evaluating about the effects of hypercholesterolemia on CC and main arteries. This study was designed to assess and compare the effects of hypercholesterolemia in different arteries and CC isolated from cholesterol-fed rabbits and the possible protective effect of resveratrol in ameliorating ED.
Materials and methods

Chemicals
Cholesterol (C8503), acetylcholine HCl (A6625), phenylephrine HCL (P6126), resveratrol (R5010), ethanol, and all reagents used to prepare the Krebs solution were purchased from Sigma Aldrich (St Louis, MO, USA). Resveratrol was dissolved in ethanol, and for other chemicals, distilled water was used. Krebs solution used for arteries consisted of (mM) NaCl 118. 
Animals and isolated tissue bath experiments
This study was approved by Dokuz Eylul University Ethic Committee. Three groups of New Zealand white male 3 months old rabbits weighing 2600-3200 g were used. Rabbits were housed identically in individual cages in an airconditioned room under a 12 h light dark cycle. For three groups, 20 rabbits in total were used. Each group was fed according to the following scheme: control group maintained a standard diet; high-cholesterol group sustained a diet containing 2% cholesterol for 6 weeks; resveratrol group received a diet containing 2% cholesterol plus orally resveratrol 4 mg kg -1 per day in drinking water for 6 weeks. All the animals were initially fed with a standard laboratory diet for at least 7 days before the outset of the study. Tap water was available ad libitum. Weight was determined before applying the treatment and then every week until the end of the experiment. The blood samples were collected from the ear vein, and total serum cholesterol levels were measured at the beginning and at the end of the experiment by enzymatic assays (Roche Diagnostic, Tokyo, Japan) and expressed in mg per 100 ml.
The animals were anesthetized with 60 mg kg -1 thiopental and killed by exsanguination from the common carotid in the 7th week of the experiment. The TA, RA, MA, and CC were rapidly removed and placed in Krebs-Henseleit solution of the given composition. Adherent fat and surrounding tissue were cleaned off and were cut into rings approximately 2-3 mm wide for the arteries and 3 Â 3 Â 4 mm 3 strips for CC. The tissues were then suspended between two stainless steel hooks in organ baths containing 10 ml of Krebs-Henseleit solution. The solution was kept at 37 1C and gassed continuously with a 95% O 2 and 5% CO 2 gas mixture at pH 7.35. The arteries were mounted under 1 g and CC under 1.5 g tension. Tissues were washed with Krebs solution at each 15 min, during the 60 min for arteries and 1.5 h for CC resting period. Isometric tensions were recorded with an amplifier system (MP30 Biopac systems Inc., Santa Barbara, CA, USA) on a computer by using Biopac computer program.
After the equilibration period, all tissues were contracted with KCl, and after 30 min of wash-out period, 3 Â 10 À6 M phenylephrine was applied. When the tissues reached plato, cumulative doses of acetylcholine (10 À8 -10 À5 M) were applied. Then, 30 min after having been washed out, they were once exposed to 3 Â 10 À6 M phenylephrine and after that a concentration-response curve with half logs of sodium nitroprusside 10 À9 -10 À6 M were applied. All data were expressed as mean ± s.e.m. Relaxation responses to acetylcholine and sodium nitroprusside were calculated according to the percentage of phenylephrine contraction.
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Statistical analysis
The statistical significance of differences of groups was analyzed by one-way ANOVA or Student's t-test. P-values o0.05 were considered significant.
Results
General results
There were no statistical differences in body weights observed during the experimental period (P40.05). Initial weights were 2851±58.0, 2894±67.0, and 2943 ± 47.3 g for control, hypercholesterolemic, and cholesterol plus resveratrol group, respectively. Six weeks later, at the end of treatments, the weights were 2894 ± 68.5 g for control group, 2691 ± 142.2 g for hypercholesterolemic group, and 2986 ± 49.2 g for resveratrol group. There were no statistical significances between cholesterol levels at the beginning of the study (data not shown). At the end of 6-week feeding period, serum concentrations of total cholesterol were 26.3 ± 2.02, 1825.0 ± 197.60, and 1661.0 ± 147.60 mg per 100 ml for control, hypercholesterolemic, and resveratrol group, respectively. Mean serum cholesterol level of hypercholesterolemic group was significantly increased at the end of 6-week cholesterol diet (Po0.001 for control vs hypercholesterolemic and resveratrol group, P40.05 for hypercholesterolemic vs resveratrol).
KCl responses for control, hypercholesterolemic, and resveratrol groups in RA, MA, TA, and CC were also compared. There was also no significance in groups (Table 1) . In all groups, comparison of the first and the second phenylephrine contractions to exclude any tissue damage showed no statistical significance (Table 2) .
RA responses
Responses to acetylcholine in RA rings. Cumulative doses of acetylcholine (10 À8 -10 À5 M) caused an endothelium-dependent relaxation in a concentrationresponse manner in all the groups studied (Figure 1a) . Endothelium-dependent relaxation strongly decreased in the hypercholesterolemic group with respect to the control and resveratrol group. Maximum relaxation induced by acetylcholine was 20.15±1.93%, 8.88±1.97%, and 20.40± 2.24% for control, hypercholesterolemic, and resveratrol group, respectively. Resveratrol was able to restore endothelium-dependent relaxation to the value of control group and no statistical difference was observed between resveratrol and control groups (P40.05).
Responses to sodium nitroprusside in RA rings. The endothelium-independent relaxation was tested with sodium nitroprusside in all groups studied (Figure 1b) . Moreover, we did not find any differences in terms of maximum relaxation and PD 2 values among the groups. Maximum relaxation responses were 36.64 ± 5.44%, 32.96 ± 2.46%, and 31.77 ± 5.72% and the PD 2 values were 7.08 ± 0.22, 7.11±0.22, and 7.72±0.24 for control, hypercholesterolemic, and resveratrol group, respectively. E max and PD 2 values showed no statistical differences between groups.
MA responses
Responses to acetylcholine in MA rings. Acetylcholine (10 À8 -10 À5 M) caused an endothelium-dependent relaxation in a concentration-response manner in all the groups studied (Figure 2a) . Despite relaxation responses in control and resveratrol group, hypercholesterolemia caused contraction in MA. Maximum relaxation induced by acetylcholine (Figure 3a) . Hypercholesterolemic group gave limited relaxation response to acetylcholine. Resveratrol-treated group ameliorated the effects of hypercholesterolemia. There was a statistical difference between resveratrol-treated group vs control and hypercholesterolemia (Po0.001 for each group).
Responses to sodium nitroprusside in TA artery rings. No statistical difference was observed between the maximum relaxation responses and PD 2 values of groups. The relaxation results for SNP were 41.91±5.18% for control, 43.36±2.98% for hypercholesterolemia, and 41.94±3.87% for resveratrol-treated groups (Figure 3b) . PD 2 values were 6.9 ± 0.10, 6.5 ± 0.04, and 6.7 ± 0.11 for control, hypercholesterolemic, and resveratrol group, respectively (P40.05).
CC responses
Responses to acetylcholine in CC. A total of 3 Â 10 -6 M phenylephrine was applied to the CC of Treatment effects of resveratol on hypercholesterolemia BC Soner et al three groups and responses to acetylcholine were evaluated. The results were 57.9±6.69%, 15.8± 1.65%, and 41.5 ± 4.47% for control, hypercholesterolemic, and resveratrol group, respectively (Figure 4a ). Control group had the maximum relaxation and even resveratrol group could not recover the responses significantly, and there was a significant statistical difference between hypercholesterolemia groups (Po0.05 for resveratrol vs control and hypercholesterolemia; Po0.001 control vs hypercholesterolemia).
Responses to sodium nitroprusside CC rings. No statistical difference was observed between the maximum relaxation responses and PD 2 values of three groups. The relaxation results for SNP were 55.13 ± 7.56%, 53.89 ± 4.97%, and 54.25 ± 7.60 for control, hypercholesterolemia, and resveratroltreated groups, respectively (Figure 4b ). PD 2 values were 6.9 ± 0.1 for control, 6.50 ± 0.04 for hypercholesterolemic, and 6.65 ± 0.11 for resveratrol group (P40.05).
Discussion
Our study, for the first time, provides evidence that resveratrol restores the major changes on CC and arteries isolated from high cholesterol-fed rabbits without any significant differences in plasma cholesterol levels. Maximum effect of hypercholesterolemia was seen on MAwhen compared with RA, CC, and TA. Our results for KCl contractions and SNP relaxation responses showed no statistical differences in three groups. It is known that KCl responses are used for evaluating the vascular smooth muscle responses. 12 In our results, we have shown that resveratrol-treated group and hypercholesterolemic group had no significant differences on non-receptor-mediated contraction. Taking into account the present data, we can postulate that the protective effect of resveratrol on endothelial dysfunction constituted by hypercholesterolemia was due to its protective effect on endothelium.
It is well known that endothelium injury occurs in the vascular rings of atherosclerotic animals and this Treatment effects of resveratol on hypercholesterolemia BC Soner et al is defined as the first step in atherosclerotic plaque development. [13] [14] [15] This injury leads to an alteration in the normal functionality of endothelium with a decrease in endothelium-dependent relaxation induced by acetylcholine. 16, 17 It has been shown that the relationship between endothelial dysfunction and relaxation response induced by acetylcholine is similar. 18 In a study about the effect of cholesterol, Sanz et al. have indicated that the degenerative effect of hypercholesterolemia on endothelial responses was similar with cholesterol levels. 19 Even some studies have shown that resveratrol has an effect of decreasing serum total cholesterol levels; 20, 21 on the other hand, some of the studies, similar to our results, found no significant changes in serum total cholesterol levels. 22, 23 Besides aorta, in our study when compared with other tissues, the maximum benefit of resveratrol was seen on RA. When taken into account that the 80% of renovascular stenotic diseases are related with atherosclerosis and the diseases have been associated with systemic coroner artery, aorta, and cerebral arterial diseases, 24 this effect of resveratrol may be used to prevent great percentage of renovascular stenotic diseases.
Our results have shown that hypercholesterolemia had the maximum and probably the first effect on MA endothelium. Impaired vascular relaxation responses to Ach in different tissues can be attributed to blunted endothelium-dependent relaxation to various receptor-dependent agonists, including Ach. 25 As it has been shown, the M 3 subtype muscarinic receptors, which are responsible for relaxation, are located on endothelial cells of the vasculature, 26 and when stimulated, they release NO, which diffuses to adjacent smooth muscle and causes them to relax. 27 Vasoconstriction responses to Ach in endothelium damaged hypercholesterolemic MA is a result of Ach, which stimulates M 2 receptors on vascular smooth muscle cells and cause vasoconstriction. 28 In atherosclerosis, it has been shown that celiac, superior, and inferior MA tolerates each other. Even atherosclerosis on MA is seen frequently, intestinal ischemia is rarely seen. 29, 30 This makes CC more important tissue because endothelial dysfunction-as a precursor of atherosclerosis-can be clinically anticipated with the complaint of ED.
Hypercholesterolemia is one of the frequent causes of ED. It has been disclosed that hypercholesterolemic patients' CC tissues have lower endothelium-dependent relaxation responses to acetylcholine when compared with normocholesterolemic population. Similar results can be obtained from hypercholesterolemic animal tissues. 31 As accepted, ED can be the precursor of vasculopaties and that is why penis has been recognized as the barometer of endothelial system health. 32 Various molecules have been studied to obtain a protective effect for hypercholesterolemia on ED. In our study, we have revealed for the first time that resveratrol had recovered the acetylcholine responses of CC when compared with hypercholesterolemic tissues.
Conclusion
Resveratrol normalizes endothelial dysfunction caused by atherogenic diet on rabbits. The effect of resveratrol is through its protective effect on endothelium without any changes on serum cholesterol levels. Resveratrol might be an effective treatment in the prevention of pathophysiological changes on arteries and ED as in clinical alterations, which occur during atherosclerotic development.
Under light of these results, further clinical studies with resveratrol about precluding initial effects of hypercholesterolemia on ED will be illuminative. This protective effect may also be guiding on a new molecule for the prevention of coronary arterial disease and renovascular diseases in hypercholesterolemic patients.
